OverviewChartNewsTraderScreen

UniCredit Knock-Out AMD 17.07.202.../  DE000HD4JF79  /

Frankfurt Zert./HVB
18/06/2024  19:34:23 Chg.+0.390 Bid21:59:13 Ask21:59:13 Underlying Strike price Expiration date Option type
8.610EUR +4.74% -
Bid Size: -		 -
Ask Size: -		 ADVANCED MIC.DEV. D... - - 17/07/2024 Call
GlobeNewswire 02:57 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 18/06 4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire 18/06 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
GlobeNewswire 17/06 D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
TeleTrader 17/06 Nasdaq opens higher with Nvidia at new record high
GlobeNewswire 14/06 Sharecare wins 22 Digital Health Awards in Spring 2024 competition
GlobeNewswire 14/06 GRANITESHARES HITS $6 BILLION AUM AS NVDL SURGES
GlobeNewswire 14/06 Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire 13/06 Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire 13/06 Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire 12/06 Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire 12/06 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 12/06 Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire 11/06 Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
GlobeNewswire 11/06 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 11/06 YieldMax™ Launches Option Income Strategy ETF on Snowflake (SNOW)
GlobeNewswire 10/06 AMD to Present at the UBS Women in Tech Summit
GlobeNewswire 10/06 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire 08/06 4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire 06/06 AMD to Present at the Nasdaq London Investor Conference
GlobeNewswire 05/06 Ocular Therapeutix® to Host Investor Day on June 13, 2024
GlobeNewswire 05/06 YieldMax™ ETFs Announces Monthly Distributions on MSTY (106.33%), NVDY (101.82%), CONY (84.85%), YBI...
GlobeNewswire 05/06 Micron Samples Next-Gen Graphics Memory for Gaming and AI
GlobeNewswire 04/06 Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 03/06 Coherent Appoints Jim Anderson as Chief Executive Officer